AEP
45
5
BF.B
35
2
INTC
35
4
CINF
24
-8
ABT
54
4
NWSA
69
4
ED
39
8
MTB
38
4
EBAY
42
2
TROW
37
8
RL
73
5
SPG
45
2
THC
52
9
SNA
56
3
PNW
55
3
R
55
-2
MO
47
6
PWR
63
3
ORCL
49
3
FE
34
4
AEP
45
5
BF.B
35
2
INTC
35
4
CINF
24
-8
ABT
54
4
NWSA
69
4
ED
39
8
MTB
38
4
EBAY
42
2
TROW
37
8
RL
73
5
SPG
45
2
THC
52
9
SNA
56
3
PNW
55
3
R
55
-2
MO
47
6
PWR
63
3
ORCL
49
3
FE
34
4
Financhill
Back

BioLine Rx 10K Form

Sell
14

BLRX
BioLine Rx

Last Price:
$0.20
Seasonality Move:
-8.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BLRX News And Ratings

See the #1 stock for the next 7 days that we like better than BLRX

BLRX Financial Statistics

Sales & Book Value

Annual Sales: $4.8M
Cash Flow: $-9.8M
Price / Cash Flow: 0
Annual Sales: $0.11
Price / Book: 1.98

Profitability

EPS (TTM): -0.22640
Net Income (TTM): $-19.9M
Gross Margin: $1.1M
Return on Equity: -160.88%
Return on Assets: -34.86%

BioLine Rx Earnings Forecast

Key BioLine Rx Financial Ratios

  • The Gross Profit Margin over the past 14 years for BLRX is 23.08%.
  • The Selling, General & Administrative Expenses for BLRX have been equal to 650.63% of Gross Profit Margin.
  • The Research & Development expenses have been 260.81% of Revenue.
  • The Interest Expense is -3.54% of Operating Income.
  • The Net Earning history of BLRX is -1,262.79% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 9 years.

BioLine Rx Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BLRX
CUSIP: 09071M
Website: biolinerx.com

Debt

Debt-to-Equity Ratio: 3.27
Current Ratio: 1.52
Quick Ratio: 1.33

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BLRX Technical Analysis vs Fundamental Analysis

Sell
14
BioLine Rx (BLRX) is a Sell

Is BioLine Rx a Buy or a Sell?

  • BioLine Rx stock is rated a Sell
    The current BioLine Rx [BLRX] share price is $0.20. The Score for BLRX is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.